More than 150 participants attended the second edition of the PhD Day at the Vall d’Hebron Campus. A day marked…
en_news
Announced by the European Medicines Agency (EMA) last month, June 21, the highly selective and potent VEGFR inhibitor fruquintinib has…
Extracellular vesicles shed by prostate cancer cells to the bloodstream contain tumor-derived material that can be used as biomarkers of…
The Evaluation Commission of health research institutes of the Instituto de Salud Carlos III has unanimously renewed the accreditation of…
This resource offers recommendations for written, oral, and visual communication in Catalan and English, aimed at research center personnel and…
Recently presented at the 2024 ASCO Annual Meeting and published in parallel in The Lancet Oncology, results of the OPTIMIZE-1…
Reported today during a Proffered Paper session at the ESMO Gastrointestinal Cancers Annual Congress (ESMO GI) 2024*, first health-related quality…
On the occasion of International LGBTQIA+ Pride Day, on June 28th, VHIO shows its commitment to diversity and equality. The…
Published by ESMO’s Daily Reporter, Elena Garralda’s latest On target column explores the promise of neoadjuvant immunotherapy in the treatment…
The sixth episode of the Cancer 360º podcast entitled: “Comprehensive care in oncology” is out! A chapter where the journalist…
